Skip to content

Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)

Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03195062
Acronym
FruPP
Enrollment
9
Registered
2017-06-22
Start date
2017-03-23
Completion date
2018-08-31
Last updated
2018-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Test Meal

Keywords

Fructose, Obesity, Metabolism, Post-prandial kinetics

Brief summary

In parallel to the dramatic rise in metabolic diseases and diabetes observed over the past fifty years, the generalization of added sugar in processed food led to a marked increase in fructose consumption in almost all countries, and epidemiological studies demonstrated that the consumption of sugar-sweetened beverage (containing at least 50% of fructose) is associated with the development of diabetes, hepatic steatosis, dyslipidemia and obesity. The objective of the study is to measure the amount of fructose that escape first-pass hepatic extraction after oral ingestion (fructose+glucose), and gain insights into its metabolic fates with the use of tracers.

Interventions

OTHERTest meal

Liquid test meal (fructose+glucose)

Sponsors

University of Lausanne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged from 18 to 40 years * Body Mass Index of 18.5 to 25 kg/m² * Sex male of female

Exclusion criteria

* Fructose intolerance * Antidiabetic and hypolipemic drugs * Alcohol consumption \>10g/day * Severe eating disorders * Severe psychological problems * Vegetarian diet or other specific diet * Consumption of illicit substances * Pregnancy * Weight gain or weight loss \> 3 kg in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Measurement of the amount of fructose that escape first-pass hepatic extraction after oral ingestion.The quantity of 13C fructose will be calculated, during the post prandial period, until 240 min.Calculation with 13C fructose enrichment in blood samples at T0; 30; 60; 90; 120; 150; 180; 210 and 240 min.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026